<?xml version="1.0"?>
  <rss version="2.0">
    <channel>
      <title>Idiopathic Thrombocytopenia Purpura News : GoldBamboo.com</title>
      <link>http://goldbamboo.com/</link>
      <description>Idiopathic Thrombocytopenia Purpura News from GoldBamboo.com</description>
      <language>en-us</language>
      <copyright>&amp;copy; 2005, Gold Bamboo LLC, All Rights Reserved</copyright>
      
	<item>
        <title>Antibiotic Vancomycin May Trigger Dangerously Low Platelet Count</title>
        <link>http://goldbamboo.com/news-a223869.html</link>
        <description>Researchers at the Medical College of Wisconsin in Milwaukee and the BloodCenter of Wisconsin's Blood Research Institute have linked vancomycin to an abnormal decrease in blood platelet count, a condition called thrombocytopenia. If accompanied by uncontrollable bleeding, thrombocytopenia can be fatal. The study led by Annette Von Drygalski, M.D. [click link for full article]</description>
		 <pubDate>Sun, 04 Mar 2007 08:00 EST</pubDate>
	</item>
	<item>
        <title>New Study Finds Antibiotic Vancomycin May Trigger Dangerously Low Platelet Count</title>
        <link>http://goldbamboo.com/news-a223825.html</link>
        <description>The antibiotic vancomycin often used in intensive care units is considered the drug of choice for the treatment of staphylococci (staph) infections that are resistant to most other antibiotics. Researchers at the Medical College of Wisconsin in Milwaukee and the BloodCenter of Wisconsin's Blood Research Institute have linked vancomycin to an abnormal decrease in blood platelet count, a condition called thrombocytopenia. If accompanied by uncontrollable bleeding, thrombocytopenia can be fatal.</description>
		 <pubDate>Fri, 02 Mar 2007 04:00 EST</pubDate>
	</item>
	<item>
        <title>InterMune Discontinues Phase 3 INSPIRE Trial Of Actimmune In Idiopathic Pulmonary Fibrosis</title>
        <link>http://goldbamboo.com/news-a224222.html</link>
        <description>InterMune, Inc. (Nasdaq: ITMN) today announced that it has discontinued the Phase 3 INSPIRE  clinical trial evaluating Actimmune(R) (interferon gamma-1b) in patients with idiopathic pulmonary fibrosis (IPF) based upon the recommendation of the study's independent data monitoring committee (DMC). [click link for full article]</description>
		 <pubDate>Tue, 06 Mar 2007 08:00 EST</pubDate>
	</item>
	<item>
        <title>Takeda And Tap To Promote Sucampo's Amitiza In The US For Chronic Idiopathic Constipation</title>
        <link>http://goldbamboo.com/news-a223361.html</link>
        <description>Takeda Pharmaceuticals North America, Inc. ("Takeda") and TAP Pharmaceutical Products Inc. ("TAP") has announced an agreement with TAP to promote Sucampo Pharmaceuticals, Inc.'s ("Sucampo") AMITIZA® (lubiprostone) approved for the treatment of chronic idiopathic constipation in adults in the United States. [click link for full article]</description>
		 <pubDate>Thu, 01 Mar 2007 02:00 EST</pubDate>
	</item>
	<item>
        <title>Online Tool Helps Physicians Improve Care Of Patients With Bleeding Disorder</title>
        <link>http://goldbamboo.com/news-a219655.html</link>
        <description>Physicians who  treat a blood disorder called idiopathic thrombocytopenic purpura (ITP),  characterized by easy bruising and excessive bleeding, now have a new tool to help them provide the best care for patients with this disease. [click link for full article]</description>
		 <pubDate>Thu, 08 Feb 2007 08:00 EST</pubDate>
	</item>
	

    </channel>
  </rss>
